Redefining the treatment of Chagas disease: a review of recent clinical and pharmacological data for a novel formulation of nifurtimox.
Saved in:
| Title: | Redefining the treatment of Chagas disease: a review of recent clinical and pharmacological data for a novel formulation of nifurtimox. |
|---|---|
| Authors: | Altcheh J; Hospital de Niños Ricardo Gutiérrez and Instituto Multidisciplinario de Investigacion en Patologias Pediatricas (IMIPP), CONICET-GCBA, Buenos Aires, Argentina., Grossmann U; Bayer AG, Research & Development, Clinical Development & Operations, Acute & Chronic Care & Pediatrics, Berlin, Germany., Stass H; Bayer AG, Clinical PK CV, Research & Development - Pharmaceuticals, Wuppertal, Germany., Springsklee M; Bayer AG, Pharmaceuticals, Chief Medical Office, CMO MA Sustainability, Wuppertal, Germany., Garcia-Bournissen F; Department of Paediatrics, Schulich School of Medicine and Dentistry, Western University, London, Ontario, Canada. |
| Source: | PLoS neglected tropical diseases [PLoS Negl Trop Dis] 2025 Feb 25; Vol. 19 (2), pp. e0012849. Date of Electronic Publication: 2025 Feb 25 (Print Publication: 2025). |
| Publication Type: | Journal Article; Review |
| Journal Info: | Publisher: Public Library of Science Country of Publication: United States NLM ID: 101291488 Publication Model: eCollection Cited Medium: Internet ISSN: 1935-2735 (Electronic) Linking ISSN: 19352727 NLM ISO Abbreviation: PLoS Negl Trop Dis Subsets: MEDLINE |
| Database: | MEDLINE Ultimate |
|
Full text is not displayed to guests.
Login for full access.
|
|
Be the first to leave a comment!
